Can Propranolol Cause Diarrhea?

Propranolol, one of the most widely prescribed beta-blockers, can cause diarrhea as a recognized side effect. The frequency varies widely depending on the patient population and dose, ranging from around 1% in some studies to over 50% in others. Diarrhea is not the first side effect most people associate with a heart or blood-pressure medication, which is why it often catches patients off guard and sometimes goes unrecognized as drug-related for weeks or months.

How Common Is Propranolol-Related Diarrhea?

The rates reported in clinical studies span a surprisingly wide range, and much of that variation comes down to who is taking the drug and at what dose. Among infants treated with propranolol for hemangiomas (benign vascular tumors), diarrhea is frequently the single most reported side effect. One study of infants with hemangiomas found diarrhea in about 52% of patients, making it the leading adverse reaction in that group.¹ Another pediatric study reported diarrhea with weight loss as the most common adverse effect, occurring in roughly a third of patients who experienced any side effect at all.²

In adults, the picture tends to be less dramatic. Adults taking propranolol for conditions like high blood pressure, migraine prevention, or anxiety generally report diarrhea at lower rates, though precise numbers from large adult-focused trials are harder to pin down because diarrhea often goes unreported or gets attributed to other causes. A large pediatric cohort of nearly 600 infants treated for hemangiomas reported diarrhea in about 1.2% of cases, which sits at the low end of estimates and may reflect differences in how side effects were tracked.³ The takeaway is that diarrhea is a real and sometimes common side effect, but your individual risk depends heavily on your dose, your age, and what condition you are taking it for.

Why a Heart Medication Affects Your Gut

Beta-adrenergic receptors are not just in your heart. They line the walls of your intestines, and they play a role in regulating how fast food moves through your digestive tract. Under normal conditions, the sympathetic nervous system (your “fight or flight” system) uses beta receptors to slow gut motility, essentially telling the intestines to relax so your body can focus on other priorities. When propranolol blocks those receptors, the braking signal weakens and the gut speeds up.

Research has directly measured this effect. In one study, intravenous propranolol significantly increased pressure activity in the sigmoid colon, the lower portion of the large intestine responsible for forming and moving stool. Pressure roughly doubled from baseline, and even a lower dose produced a measurable increase.⁴ In the small intestine, the story is similar. Propranolol consistently hastened the time it took for contents to travel from the mouth to the cecum (the junction between the small and large intestine), cutting median transit time roughly in half compared to a placebo.⁵

Faster transit means your intestines have less time to absorb water from digesting food, and that is the basic recipe for loose or watery stools. The effect is not unique to propranolol; the same study found that atenolol, a beta-1-selective blocker, also sped up transit, suggesting this is a class-wide phenomenon tied to beta-receptor blockade rather than something peculiar to propranolol’s chemistry.⁵ That said, propranolol blocks both beta-1 and beta-2 receptors (it is “non-selective”), and there is reason to think the additional beta-2 blockade in the gut wall contributes to stronger motility effects than more selective beta-blockers produce in some patients.

Blood Flow Changes Add Another Layer

Beyond motility, propranolol also affects blood flow to the intestines. Animal studies have shown that propranolol causes vasoconstriction in the splanchnic (gut-feeding) blood vessels, significantly reducing blood flow to the portal venous territory.⁶ This reduction in intestinal blood flow has been confirmed in both normal subjects and those with portal hypertension, where propranolol produced measurable vasoconstriction and decreased flow.⁷

Reduced blood flow to the gut can compromise the intestinal lining’s ability to absorb nutrients and water normally, potentially compounding the diarrhea caused by increased motility. For most healthy adults on standard doses, this effect is subtle. But in patients with liver disease who already have abnormal gut blood flow, or in people taking high doses, the combined impact of faster transit and reduced intestinal perfusion can make diarrhea more likely and more pronounced.

Dose Dependence and the Role of Formulation

One of the clearest clinical demonstrations of dose-dependent diarrhea comes from an early case report of a 71-year-old woman who developed diarrhea and weight loss while taking propranolol at 20 mg four times daily. When the drug was stopped, her diarrhea resolved quickly. Her doctor then restarted propranolol at a lower dose of 10 mg four times daily, and she had no problems. But when the dose was increased back to 20 mg four times daily, the diarrhea returned. Stopping it a second time resolved the problem again.⁸ This rechallenge pattern strongly implicates the drug and suggests the effect is dose-related rather than coincidental.

Formulation also seems to matter. A study comparing propranolol tablets to an oral liquid solution in infants found that diarrhea occurred in about 29% of those taking tablets versus roughly 13% of those on the oral solution, a statistically significant difference.⁹ The reason is not entirely clear, but differences in how quickly the drug is released and absorbed from different formulations could affect peak concentrations in the gut, and higher local concentrations may provoke stronger motility responses. Inactive ingredients in different formulations, such as sugar alcohols sometimes used in liquid preparations, can also play a role in GI tolerance, though the tablet group’s higher rate in this study suggests the issue is more about the drug itself than excipients.

The Paradox of Propranolol Treating Diarrhea

Here is where things get counterintuitive. Despite propranolol’s ability to cause diarrhea, it has also been used to treat diarrhea in specific clinical situations. A well-documented case involved a young man with hyperthyroidism whose only prominent symptom was severe, chronic diarrhea and a 14-kilogram weight loss over five months. When his overactive thyroid was identified as the cause, propranolol was used to control the diarrhea, and it worked promptly.¹⁰

This is not as contradictory as it sounds. In hyperthyroidism, excess thyroid hormone overstimulates the sympathetic nervous system and dramatically accelerates gut motility through a different pathway. Propranolol blocks those excess peripheral effects of thyroid hormone, effectively calming the overdriven nervous system and slowing the gut back toward normal. In a person with normal thyroid function, the same blockade removes baseline sympathetic braking and speeds things up instead. Whether propranolol helps or harms your digestion depends on which direction your gut motility is already leaning.

A similar logic applies in liver cirrhosis. Patients with advanced cirrhosis often have sluggish gut motility due to their disease, which leads to bacterial overgrowth in the small intestine. In a study of cirrhosis patients, propranolol actually improved intestinal motility, cutting the transit time from a sluggish 180 minutes down to 139 minutes, and reduced rates of small intestinal bacterial overgrowth.¹¹ In animal models of cirrhosis, propranolol also accelerated intestinal transit enough to decrease bacterial overgrowth and bacterial translocation (bacteria crossing from the gut into the bloodstream).¹² For these patients, faster transit is therapeutic. But for someone whose gut was moving at a normal speed before starting the drug, the same acceleration can mean loose stools or outright diarrhea.

Propranolol and the Gut Microbiome

Beyond its effects on motility and blood flow, emerging research suggests propranolol may reshape the bacterial community living in your intestines. A rodent study examining the effects of beta-blockade after trauma found that propranolol-treated animals showed significantly greater gut microbiome diversity compared to untreated counterparts after seven days, with increases in commensal (beneficial) bacteria like Oscillospiraceae and Clostridia that persisted at fourteen days.¹³

This is early-stage research, and it was conducted in a specific context (animals recovering from trauma and chronic stress), so drawing broad conclusions for everyday propranolol users would be premature. Still, it raises an interesting possibility: propranolol’s effects on gut motility and blood flow may create downstream shifts in which bacteria thrive, potentially influencing digestive symptoms in ways that go beyond simple “food moves faster.” Changes in microbial composition can affect gas production, water secretion, and how well the intestinal lining functions, all of which could contribute to diarrhea or other GI complaints. This is a space where the science is still catching up to clinical observation.

When Diarrhea on Propranolol Warrants Concern

Most propranolol-related diarrhea is mild and manageable. But in rare cases, propranolol has been associated with mesenteric ischemia, a serious condition where blood flow to the intestines drops enough to damage tissue. One documented case involved a patient with hyperthyroidism who developed an acute abdomen while on propranolol therapy.¹⁴ This is exceptionally rare, but it is worth being aware of because the early symptoms of mesenteric ischemia can include diarrhea (sometimes bloody), severe abdominal pain, and nausea. If you are on propranolol and develop sudden, severe abdominal pain alongside diarrhea, that warrants immediate medical attention rather than a wait-and-see approach.

Short of that emergency scenario, diarrhea that persists for more than a few weeks, is accompanied by significant weight loss, or interferes with daily life should be discussed with your prescriber. The case report mentioned earlier illustrates that a physician might not immediately connect diarrhea to a beta-blocker, since the drug’s primary associations are cardiovascular. Patients sometimes go through extensive GI workups before anyone thinks to question the medication list.⁸

Practical Steps If You Develop Diarrhea on Propranolol

If you are taking propranolol and notice new or worsening diarrhea, there are several practical considerations before you and your doctor decide on a course of action:

• Timing matters: Diarrhea that begins within the first few days to weeks of starting propranolol or increasing the dose is more likely drug-related. Diarrhea that starts months into stable therapy may have a different cause worth investigating.
• Dose reduction: Clinical experience and case reports suggest that lowering the dose can resolve diarrhea while still providing therapeutic benefit. Some mild side effects resolve simply by adjusting when the dose is taken or modestly reducing the daily amount.¹⁵
• Formulation switch: If you are on tablets, asking about a liquid formulation (or vice versa) is reasonable, given the evidence that different formulations produce different rates of diarrhea.
• Do not stop abruptly: Propranolol should not be discontinued suddenly, especially if you are taking it for a heart condition, because abrupt withdrawal can cause rebound increases in heart rate and blood pressure. Any changes should be made in consultation with your prescriber.

If dose adjustment and formulation changes do not help, your doctor may consider switching to a different beta-blocker. Selective beta-1 blockers like metoprolol or atenolol still affect gut motility to some degree, but individual responses vary enough that a switch sometimes resolves the problem. Alternatively, if propranolol is being used for something like performance anxiety or migraine prevention, there may be non-beta-blocker alternatives worth discussing.

Why Propranolol’s Gut Effects Are Often Overlooked

Propranolol has been on the market since the 1960s, and its gastrointestinal effects have never received the same attention as its cardiovascular ones. Prescribing information lists diarrhea among possible side effects, but it tends to be buried alongside a long list of other complaints. Physicians prescribing propranolol for anxiety, tremor, or migraine prevention may not emphasize GI side effects during the initial conversation because those conditions are not typically associated with the digestive system in the prescriber’s mind.

There is also a detection problem. Mild diarrhea is common in the general population from dietary changes, stress, infections, and dozens of other causes. When a patient develops loose stools a few weeks after starting a new medication for anxiety, both the patient and the doctor may attribute it to the anxiety itself (which can cause GI symptoms) rather than the treatment. The dose-rechallenge evidence from case reports is compelling precisely because it bypasses this ambiguity: stop the drug, diarrhea stops; restart the drug, diarrhea returns.

For patients on propranolol long-term, it is also worth knowing that GI side effects sometimes diminish over weeks to months as the body adjusts. Not everyone who experiences early diarrhea will have it indefinitely. But if it does not resolve on its own within a reasonable timeframe, the strategies described above, particularly dose adjustment, remain the most practical first steps.